FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer

The new approval marks the 40th oncology indication for pembrolizumab across 19 cancer types, including two previous metastatic cervical cancer approvals.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-approves-pembrolizumab-stage-3-4a-cervical-cancer-2024a10000zt?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?